Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 17
Selected: 0
NCT IDTitle
NCT04162769A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis
NCT02044874A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
NCT00619931A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers
NCT02536404Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
NCT00529646Single-Dose Safety Study of APD791 in Healthy Volunteers
NCT03996369Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
NCT04655599Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome
NCT01093508Single-dose Safety Study of APD916 in Healthy Volunteers
NCT04043455Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)
NCT00664664Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia
NCT03139032Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations
NCT03155932Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis
NCT02447302Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis
NCT00452179Safety and Efficacy Study of APD125 in Patient With Insomnia
NCT03945188Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
NCT03155945Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain
NCT03072953Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum